BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 20622003)

  • 1. Smad4 loss is associated with fewer S100A8-positive monocytes in colorectal tumors and attenuated response to S100A8 in colorectal and pancreatic cancer cells.
    Ang CW; Nedjadi T; Sheikh AA; Tweedle EM; Tonack S; Honap S; Jenkins RE; Park BK; Schwarte-Waldhoff I; Khattak I; Azadeh B; Dodson A; Kalirai H; Neoptolemos JP; Rooney PS; Costello E
    Carcinogenesis; 2010 Sep; 31(9):1541-51. PubMed ID: 20622003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
    Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
    J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of S100A8 in pancreatic cancer-associated monocytes is associated with the Smad4 status of pancreatic cancer cells.
    Sheikh AA; Vimalachandran D; Thompson CC; Jenkins RE; Nedjadi T; Shekouh A; Campbell F; Dodson A; Prime W; Crnogorac-Jurcevic T; Lemoine NR; Costello E
    Proteomics; 2007 Jun; 7(11):1929-40. PubMed ID: 17469085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analysis of S100A9 and S100A8 expression in matched sets of macroscopically normal colon mucosa and colorectal carcinoma: the S100A9 and S100A8 positive cells underlie and invade tumor mass.
    Stulík J; Osterreicher J; Koupilová K; Knízek ; Macela A; Bures J; Jandík P; Langr F; Dedic K; Jungblut PR
    Electrophoresis; 1999; 20(4-5):1047-54. PubMed ID: 10344284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.
    Ehlermann P; Eggers K; Bierhaus A; Most P; Weichenhan D; Greten J; Nawroth PP; Katus HA; Remppis A
    Cardiovasc Diabetol; 2006 Mar; 5():6. PubMed ID: 16573830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.
    Hermani A; Hess J; De Servi B; Medunjanin S; Grobholz R; Trojan L; Angel P; Mayer D
    Clin Cancer Res; 2005 Jul; 11(14):5146-52. PubMed ID: 16033829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes.
    Nedjadi T; Evans A; Sheikh A; Barerra L; Al-Ghamdi S; Oldfield L; Greenhalf W; Neoptolemos JP; Costello E
    BMC Cancer; 2018 Dec; 18(1):1255. PubMed ID: 30558665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment.
    Kim JH; Oh SH; Kim EJ; Park SJ; Hong SP; Cheon JH; Kim TI; Kim WH
    Biochem Biophys Res Commun; 2012 Jun; 423(1):60-6. PubMed ID: 22634002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and pancreatic cancer: molecular and functional interactions between S100A8, S100A9, NT-S100A8 and TGFβ1.
    Basso D; Bozzato D; Padoan A; Moz S; Zambon CF; Fogar P; Greco E; Scorzeto M; Simonato F; Navaglia F; Fassan M; Pelloso M; Dupont S; Pedrazzoli S; Fassina A; Plebani M
    Cell Commun Signal; 2014 Mar; 12():20. PubMed ID: 24670043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
    Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
    Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significance of S100A8 and S100A9 expression in gastric cancer].
    Hu Y; Fan B; Zhang LH; Cheng XJ; Niu ZJ; Ji JF
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3369-74. PubMed ID: 24418034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-dependent tetramer formation of S100A8 and S100A9 is essential for biological activity.
    Leukert N; Vogl T; Strupat K; Reichelt R; Sorg C; Roth J
    J Mol Biol; 2006 Jun; 359(4):961-72. PubMed ID: 16690079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.
    Deng H; Ravikumar TS; Yang WL
    Cancer Lett; 2009 Aug; 281(2):220-31. PubMed ID: 19321257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of S100A8 and S100A9 in neutrophil recruitment in response to monosodium urate monohydrate crystals in the air-pouch model of acute gouty arthritis.
    Ryckman C; McColl SR; Vandal K; de Médicis R; Lussier A; Poubelle PE; Tessier PA
    Arthritis Rheum; 2003 Aug; 48(8):2310-20. PubMed ID: 12905486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100A8 and S100A9 in inflammation and cancer.
    Gebhardt C; Németh J; Angel P; Hess J
    Biochem Pharmacol; 2006 Nov; 72(11):1622-31. PubMed ID: 16846592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S100A8 and S100A9 are associated with colorectal carcinoma progression and contribute to colorectal carcinoma cell survival and migration via Wnt/β-catenin pathway.
    Duan L; Wu R; Ye L; Wang H; Yang X; Zhang Y; Chen X; Zuo G; Zhang Y; Weng Y; Luo J; Tang M; Shi Q; He T; Zhou L
    PLoS One; 2013; 8(4):e62092. PubMed ID: 23637971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion.
    Moon A; Yong HY; Song JI; Cukovic D; Salagrama S; Kaplan D; Putt D; Kim H; Dombkowski A; Kim HR
    Mol Cancer Res; 2008 Oct; 6(10):1544-53. PubMed ID: 18922970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer.
    Ehrchen JM; Sunderkötter C; Foell D; Vogl T; Roth J
    J Leukoc Biol; 2009 Sep; 86(3):557-66. PubMed ID: 19451397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer.
    Zheng P; Liu YX; Chen L; Liu XH; Xiao ZQ; Zhao L; Li GQ; Zhou J; Ding YQ; Li JM
    J Proteome Res; 2010 Oct; 9(10):4897-905. PubMed ID: 20806969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.
    Grebhardt S; Veltkamp C; Ströbel P; Mayer D
    Int J Cancer; 2012 Dec; 131(12):2785-94. PubMed ID: 22505354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.